ACTA Annual Scientific Meeting: 10-12 November 2021

This virtual event brought together a great line-up of experts in the cutting-edge design and conduct of clinical trials and registry custodianship, policy and regulation, health care service delivery, health information technology, health economics and consumer engagement.

We sincerely thank all presenters, delegates the organising committee, and our generous sponsors for their tremendous support of this event. We look forward to seeing you all at the 2022 ACTA ASM.

Delegates, we are pleased to confirm that recordings of all live presentations and on demand content will be available on the event platform until November 2022.


Registrations for the 2021 ACTA ASM have now closed.

Thank you to all delegates who attended and made this event a great success.

Theme and streams

Under the theme Strengthening the pipeline for clinical research, this event provided a great opportunity to highlight, celebrate and discuss key topics across the full clinical research spectrum. The event was delivered across 5 event streams:

Strengthening the pipeline for clinical research
STREAM 1: Translation of clinical registry findings into practiceSTREAM 2: Capacity building to optimise trial design, conduct and impactSTREAM 3: Facilitating efficient and cost-effective recruitment and completion of clinical trialsSTREAM 4: Accelerating Australian discovery and innovation through trials and well-phenotyped cohortsSTREAM 5: Australia as the “go-to” partner for global and industry supported trials
All streams highlighted consumer engagement, equity and diversity

Program and speakers

Some of our speakers included:

An update on the MRFF
Prof Ian Frazer AC
Chair, Australian Medical Research Advisory Board

National CQR and Virtual CQR Strategy
Ms Sally Rayner
Director, Quality, Performance and Reporting Section, Health Economics and Modelling Branch, Department of Health
Importance of global trial networks
Prof Anne Kelso AO
CEO, National Health and Medical Research Council

National Clinical Trials Governance Framework toward the accreditation of health services for the conduct of clinical trials
Prof Christopher Brook PSM
Chair, CTPRG
The role of AI and machine learning in trials
Prof Louisa Jorm
Foundation Director of the Centre for Big Data Research in Health, UNSW
Making AUS a strong partner and leader in genomic studies
Prof Kathryn North AC
Director, Murdoch Children's Research Institute

Thank you to our sponsors

We sincerely thank the generous sponsors who supported this event.

Thank you to our Major Sponsor:

Thank you to our Stream Sponsors:

For more information about Sponsorship Opportunities for future ACTA events, please contact us

Call for abstracts

Abstract submissions for the 2021 ACTA ASM have now closed

We sincerely thank our colleagues from across the sector who have submitted an abstract and were part of this special event.

Key dates for abstract submissions:
Call for abstracts opened30 August 2021
Call for abstracts closed5pm AEST, 20 September 2021
Authors notified of outcome15 October 2021
Final submission deadline29 October 2021

Congratulations to our Emerging Leader Investigator Award winners

Thank you to those who have submitted an abstract for consideration for our new Emerging Leader Investigator Award. This Award aims to recognise the outstanding accomplishments of young investigators in our sector. 

As determined by the ACTA ASM Organising Committee, the three young investigators with the highest-ranked abstracts were invited to give a live oral presentation in a dedicated session on Thursday, 11 November 2021.

We congratulate our three Emerging Leader Investigator Award winners:

Delegates can watch the recordings of these presentations via the links above.